Traws Pharma Ownership 2024 | Who Owns Traws Pharma Now?
Institutional Ownership
8.17%
Insider Ownership
0.78%
Retail Ownership
91.06%
Institutional Holders
25.00
Traws Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -164 | -100.00% | - | Jun 30, 2024 |
FMR LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -166 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -37,987 | -100.00% | - | Jun 30, 2024 |
Traws Pharma's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -164 | -100.00% | - | Jun 30, 2024 |
FMR LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -166 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -37,987 | -100.00% | - | Jun 30, 2024 |
The largest Traws Pharma shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Traws Pharma (ONTX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -164 | -100.00% | - | Jun 30, 2024 |
OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -166 | -100.00% | - | Jun 30, 2024 |
FMR LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -37,987 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Traws Pharma's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.16K stocks of ONTX, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TWO SIGMA INVESTMENTS, LP | - | - | - | -37,987 | -100.00% | - | Jun 30, 2024 |
FMR LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -166 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -164 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Traws Pharma's biggest institutional seller is TWO SIGMA INVESTMENTS, LP. The company sold -37.99K shares of ONTX, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TWO SIGMA INVESTMENTS, LP | - | - | - | -37,987 | -100.00% | - | Jun 30, 2024 |
FMR LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -166 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -164 | -100.00% | - | Jun 30, 2024 |
Traws Pharma's largest sold out institutional shareholder by shares sold is TWO SIGMA INVESTMENTS, LP, sold -37.99K shares, valued at -, as of undefined.
Traws Pharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
Principal Exchange-Traded Funds | 0.10% | 1,258,392 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.02% | 10,015,583 | - | - | Mar 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.01% | 216,619 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 106,675 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 687,631 | -321,970 | -31.89% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 181,873 | -769 | -0.42% | Feb 29, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 8,811 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 101,696 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 14,441 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 7,111 | - | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 36,517 | - | - | Jan 31, 2024 |
KINETICS PORTFOLIOS TRUST | 0.00% | 160 | - | - | Mar 31, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 586 | - | - | Mar 31, 2024 |
Dimensional ETF Trust | 0.00% | 17,151 | - | - | Jan 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 1,333 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 2,348 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 2,835 | - | - | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 5,412 | - | - | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,857 | - | - | Mar 31, 2024 |
Traws Pharma's largest mutual fund holder by % of total assets is "Principal Exchange-Traded Funds", owning 1.26M shares, compromising 0.10% of its total assets.
Traws Pharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 25 | 4.17% |
31 Dec, 23 | 24 | -7.69% |
30 Sep, 23 | 26 | 13.04% |
30 Jun, 23 | 23 | - |
31 Mar, 23 | 23 | -11.54% |
31 Dec, 22 | 26 | 36.84% |
30 Sep, 22 | 19 | - |
30 Jun, 22 | 19 | -13.64% |
31 Mar, 22 | 22 | -26.67% |
31 Dec, 21 | 30 | -11.76% |
30 Sep, 21 | 34 | 88.89% |
30 Jun, 21 | 18 | - |
As of 31 Mar 24, 25 institutions are holding Traws Pharma's shares, representing an increase of 4.17% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 1,713,913 | 2.75% |
31 Dec, 23 | 1,668,027 | -6.39% |
30 Sep, 23 | 1,781,920 | -4.00% |
30 Jun, 23 | 1,856,157 | 30.15% |
31 Mar, 23 | 1,426,208 | -8.10% |
31 Dec, 22 | 1,551,940 | -8.64% |
30 Sep, 22 | 1,698,718 | -4.07% |
30 Jun, 22 | 1,770,808 | -5.90% |
31 Mar, 22 | 1,881,865 | -19.43% |
31 Dec, 21 | 2,335,610 | -9.92% |
30 Sep, 21 | 2,592,742 | 67.36% |
30 Jun, 21 | 1,549,242 | - |
Traws Pharma (ONTX) has 1.71M shares outstanding as of 31 Mar 24, up 2.75% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 8.17% | 12.95% |
31 Dec, 23 | 7.94% | 11.01% |
30 Sep, 23 | 8.49% | 10.83% |
30 Jun, 23 | 8.86% | 19.13% |
31 Mar, 23 | 6.80% | 12.35% |
31 Dec, 22 | 7.42% | 11.25% |
30 Sep, 22 | 8.12% | 11.32% |
30 Jun, 22 | 8.47% | 10.45% |
31 Mar, 22 | 9.00% | 4.68% |
31 Dec, 21 | 13.88% | 5.27% |
30 Sep, 21 | 16.23% | 16.84% |
30 Jun, 21 | 9.82% | - |
As of 31 Mar 24, Traws Pharma is held by 8.17% institutional shareholders, representing a 12.95% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | 8 | - |
31 Dec, 23 | 8 | -11.11% |
30 Sep, 23 | 9 | -18.18% |
30 Jun, 23 | 11 | 83.33% |
31 Mar, 23 | 6 | -45.45% |
31 Dec, 22 | 11 | 175.00% |
30 Sep, 22 | 4 | -55.56% |
30 Jun, 22 | 9 | - |
31 Mar, 22 | 9 | -10.00% |
31 Dec, 21 | 10 | -54.55% |
30 Sep, 21 | 22 | 22.22% |
30 Jun, 21 | 18 | - |
8 institutional shareholders have increased their position in ONTX stock as of 31 Mar 24 compared to 8 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | 6 | 20.00% |
31 Dec, 23 | 5 | - |
30 Sep, 23 | 5 | 150.00% |
30 Jun, 23 | 2 | -71.43% |
31 Mar, 23 | 7 | -12.50% |
31 Dec, 22 | 8 | 33.33% |
30 Sep, 22 | 6 | 100.00% |
30 Jun, 22 | 3 | -57.14% |
31 Mar, 22 | 7 | -36.36% |
31 Dec, 21 | 11 | 57.14% |
30 Sep, 21 | 7 | - |
30 Jun, 21 | - | - |
6 institutional shareholders have reduced their position in ONTX stock as of 31 Mar 24 compared to 5 in the previous quarter (a 20.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 25 | 4.17% | 1,713,913 | 2.75% | 8.17% | 12.95% | 8 | - | 6 | 20.00% |
31 Dec, 23 | 24 | -7.69% | 1,668,027 | -6.39% | 7.94% | 11.01% | 8 | -11.11% | 5 | - |
30 Sep, 23 | 26 | 13.04% | 1,781,920 | -4.00% | 8.49% | 10.83% | 9 | -18.18% | 5 | 150.00% |
30 Jun, 23 | 23 | - | 1,856,157 | 30.15% | 8.86% | 19.13% | 11 | 83.33% | 2 | -71.43% |
31 Mar, 23 | 23 | -11.54% | 1,426,208 | -8.10% | 6.80% | 12.35% | 6 | -45.45% | 7 | -12.50% |
31 Dec, 22 | 26 | 36.84% | 1,551,940 | -8.64% | 7.42% | 11.25% | 11 | 175.00% | 8 | 33.33% |
30 Sep, 22 | 19 | - | 1,698,718 | -4.07% | 8.12% | 11.32% | 4 | -55.56% | 6 | 100.00% |
30 Jun, 22 | 19 | -13.64% | 1,770,808 | -5.90% | 8.47% | 10.45% | 9 | - | 3 | -57.14% |
31 Mar, 22 | 22 | -26.67% | 1,881,865 | -19.43% | 9.00% | 4.68% | 9 | -10.00% | 7 | -36.36% |
31 Dec, 21 | 30 | -11.76% | 2,335,610 | -9.92% | 13.88% | 5.27% | 10 | -54.55% | 11 | 57.14% |
30 Sep, 21 | 34 | 88.89% | 2,592,742 | 67.36% | 16.23% | 16.84% | 22 | 22.22% | 7 | - |
30 Jun, 21 | 18 | - | 1,549,242 | - | 9.82% | - | 18 | - | - | - |
Traws Pharma Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Traws Pharma's stock was made by Guerin Mark Patrick on Mar 15 2024, selling 2,591 shares at $0.90 per share (valued at $2.33K).
Traws Pharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 4 | 8 | 50.00% |
Q4 2023 | 1 | - | - |
Q3 2023 | 9 | 4 | 225.00% |
Q2 2023 | 1 | 2 | 50.00% |
Q1 2023 | 9 | 6 | 150.00% |
Q4 2022 | 2 | - | - |
Q3 2022 | 11 | 6 | 183.33% |
Q2 2022 | 3 | - | - |
Q1 2022 | 12 | - | - |
Q4 2021 | 2 | 1 | 200.00% |
Q3 2021 | 17 | - | - |
Q2 2021 | 1 | - | - |
Q1 2021 | 8 | - | - |
Q4 2020 | 7 | - | - |
Q3 2020 | 12 | 3 | 400.00% |
Q2 2020 | 4 | - | - |
Q4 2019 | 17 | - | - |
Q3 2019 | 9 | 21 | 42.86% |
Q2 2019 | - | 2 | - |
Q4 2018 | 2 | 1 | 200.00% |
4 total buy trades, and 8 total sell trades (buy/sell ratio of 0.50%) were made by Traws Pharma's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q3 2023 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | 4 | - | - |
Q4 2021 | 1 | - | - |
Q3 2021 | 4 | - | - |
Q2 2021 | - | - | - |
Q1 2021 | 5 | - | - |
Q4 2020 | 7 | - | - |
Q3 2020 | - | 3 | - |
Q2 2020 | 4 | - | - |
Q4 2019 | 12 | - | - |
Q3 2019 | 3 | 17 | 17.65% |
Q2 2019 | - | 2 | - |
Q4 2018 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Traws Pharma's stocks.
Traws Pharma Peer Ownership
Ticker | Company |
---|---|
GOVX | GeoVax Labs, Inc. |
PULM | Pulmatrix, Inc. |
ADIL | Adial Pharmaceuticals, Inc. |
BPTH | Bio-Path Holdings, Inc. |
AEZS | Aeterna Zentaris Inc. |
TNXP | Tonix Pharmaceuticals Holding Corp. |
VBIV | VBI Vaccines Inc. |
DFFN | CervoMed Inc. |
JAGX | Jaguar Health, Inc. |
VXRT | Vaxart, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
MBRX | Moleculin Biotech, Inc. |
CBIO | Gyre Therapeutics, Inc. |
OCGN | Ocugen, Inc. |
PALI | Palisade Bio, Inc. |
ONTX Ownership FAQ
Who Owns Traws Pharma?
Traws Pharma is owned by institutional shareholders (8.17%), insiders (0.78%), and public (91.06%). The largest institutional shareholder of Traws Pharma is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is Principal Exchange-Traded Funds (0.10% of total shares).
Who are the major institutional shareholders of Traws Pharma?
Traws Pharma's major institutional shareholders are WELLS FARGO & COMPANY/MN, FMR LLC, OLD POINT TRUST & FINANCIAL SERVICES N A, and TWO SIGMA INVESTMENTS, LP. The top five shareholders own together 0% of the company's share outstanding.
How many Traws Pharma shareholders are there?
As of Mar 2024, there are 25 institutional shareholders of Traws Pharma.
What percentage of Traws Pharma is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 0 shares of Traws Pharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Traws Pharma is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 0 shares of Traws Pharma (ONTX), compromising 0% of the company, valued at $0.
What percentage of Traws Pharma is owned by OLD POINT TRUST & FINANCIAL SERVICES N A?
OLD POINT TRUST & FINANCIAL SERVICES N A is the third largest holder of Traws Pharma. The company owns 0 of the company's shares outstanding (worth $0).